Biorce

About

Biorce is an AI healthtech startup founded in 2024, building Aika, the first unified clinical trial infrastructure and operating system for clinical development. The platform supports the entire clinical trial lifecycle from Phase 1-3 up until market approval, enabling pharma, biotech, and CRO teams to generate compliant documents, protocols, feasibility studies, and regulatory submissions within minutes. Biorce has raised over $61.5M in funding, including a $52M Series A in February 2026.